Overview

Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The long term objective is to develop a gel to be used as a male contraceptive.
Phase:
Phase 2
Details
Lead Sponsor:
Health Decisions
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Population Council
Treatments:
Methyltestosterone
ST 1435
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate